Found 68 matching trials
Phase I Trial of Combination of FOLFIRI and SOM 230
PHASE1This is a single-arm, open-label, phase I study of combination therapy with...
Location
H. Lee Moffitt Cancer Center and Research Institute
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
PHASE1The purpose of this study is to see the safety and activity of using pasire...
Location
Emory University Winship Cancer Institute
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
PHASE1The goal of this clinical research study is to learn if the study drug SOM ...
Location
H. Lee Moffitt Cancer Center and Research Institute
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
PHASE4The purpose of this study is to allow continued use of pasireotide in patie...
Location
Ximed Research SC - SOM230B2412
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
PHASE2To evaluate efficacy, safety, pharmacokinetics and pharmacodynamics of pasi...
Location
Novartis Investigative Site
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
PHASE2The goal of this clinical research study is to learn if the study drug, Pas...
Location
Stanford Cancer Institute
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
PHASE2Study evaluating SOM230 in patients with metastatic carcinoid tumors...
Location
Cedars-Sinai Medical Center
Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer
PHASE2The majority of small cell lung cancer(SCLC)(50-100%) express somatostatin ...
Location
VA. Medical Center
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
PHASE2There are no available medical treatment options for patients with non-func...
Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery
PHASE4Postprandial hyperinsulinemic hypoglycemia is a well-known and potentially ...
Location
Zealand University Hospital